BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36800128)

  • 21. Association of Hospital Volume With Racial and Ethnic Disparities in Locally Advanced Cervical Cancer Treatment.
    Uppal S; Chapman C; Spencer RJ; Jolly S; Maturen K; Rauh-Hain JA; delCarmen MG; Rice LW
    Obstet Gynecol; 2017 Feb; 129(2):295-304. PubMed ID: 28079775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population-Based Analysis of Patient Age and Other Disparities in the Treatment of Ovarian Cancer in Central Appalachia and Kentucky.
    Ore RM; Chen Q; DeSimone CP; Miller RW; Baldwin LA; van Nagell JR; Huang B; Tucker TC; Johnson MS; Fredericks TI; Ueland FR
    South Med J; 2018 Jun; 111(6):333-341. PubMed ID: 29863220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reasons for failure to deliver National Comprehensive Cancer Network (NCCN)-adherent care in the treatment of epithelial ovarian cancer at an NCCN cancer center.
    Erickson BK; Martin JY; Shah MM; Straughn JM; Leath CA
    Gynecol Oncol; 2014 May; 133(2):142-6. PubMed ID: 24517876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Failure to comply with NCCN guidelines for the management of pancreatic cancer compromises outcomes.
    Visser BC; Ma Y; Zak Y; Poultsides GA; Norton JA; Rhoads KF
    HPB (Oxford); 2012 Aug; 14(8):539-47. PubMed ID: 22762402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Treatment Inequity and Ancestry With Pancreatic Ductal Adenocarcinoma Survival.
    Heller DR; Nicolson NG; Ahuja N; Khan S; Kunstman JW
    JAMA Surg; 2020 Feb; 155(2):e195047. PubMed ID: 31800002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Impact of Medicaid Expansion on Early-Stage Pancreatic Adenocarcinoma at High- Versus Low-Volume Facilities.
    Lima HA; Moazzam Z; Endo Y; Alaimo L; Woldesenbet S; Munir MM; Shaikh C; Resende V; Pawlik TM
    Ann Surg Oncol; 2023 Nov; 30(12):7263-7274. PubMed ID: 37368099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sociodemographic Disparities in the Receipt of Adjuvant Chemotherapy Among Patients With Resected Stage I-III Pancreatic Adenocarcinoma.
    Sanford NN; Aguilera TA; Folkert MR; Ahn C; Mahal BA; Zeh H; Beg MS; Mansour J; Sher DJ
    J Natl Compr Canc Netw; 2019 Nov; 17(11):1292-1300. PubMed ID: 31693987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thirty-day readmission rates for Medicare beneficiaries by race and site of care.
    Joynt KE; Orav EJ; Jha AK
    JAMA; 2011 Feb; 305(7):675-81. PubMed ID: 21325183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in the surgical management of early-stage hepatocellular carcinoma at minority versus non-minority-serving hospitals.
    Elshami M; Bailey L; Hoehn RS; Ammori JB; Hardacre JM; Selfridge JE; Bajor D; Mohamed A; Chakrabarti S; Mahipal A; Winter JM; Ocuin LM
    Surgery; 2023 Nov; 174(5):1201-1207. PubMed ID: 37604756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Associations of Racial and Ethnic Category, Age, Comorbidities, and Socioeconomic Factors on Concordance to NCCN Guidelines for Patients With High-Risk Biliary Tract Cancers After Surgery.
    Huang LF; Hong A; Cioffi G; Alahmadi A; Tang TY; Ocuin LM; Patil N; Bajor DL; Saltzman JN; Mohamed A; Selfridge E; Webb Hooper M; Barnholtz-Sloan J; Lee RT
    Front Oncol; 2022; 12():771688. PubMed ID: 35273909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disparities in Stage-Specific Guideline-Concordant Cancer-Directed Treatment for Patients with Pancreatic Adenocarcinoma.
    Hamad A; DePuccio M; Reames BN; Dave A; Kurien N; Cloyd JM; Shen C; Pawlik TM; Tsung A; McAlearney AS; Ejaz A
    J Gastrointest Surg; 2021 Nov; 25(11):2889-2901. PubMed ID: 33768427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment Inequity: Examining the Influence of Non-Hispanic Black Race and Ethnicity on Pancreatic Cancer Care and Survival in Wisconsin.
    Schiefelbein AM; Krebsbach JK; Taylor AK; Zhang J; Haimson CE; Trentham-Dietz A; Skala MC; Eason JM; Weber SM; Varley PR; Zafar SN; LoConte NK
    WMJ; 2022 Jul; 121(2):77-93. PubMed ID: 35857681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pancreatic resection: a key component to reducing racial disparities in pancreatic adenocarcinoma.
    Murphy MM; Simons JP; Hill JS; McDade TP; Chau Ng S; Whalen GF; Shah SA; Harrison LH; Tseng JF
    Cancer; 2009 Sep; 115(17):3979-90. PubMed ID: 19514091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disparities in Receipt of Adjuvant Therapy After Upfront Surgical Resection for Pancreatic Ductal Adenocarcinoma.
    Anteby R; Blaszkowsky LS; Hong TS; Qadan M
    Ann Surg Oncol; 2023 Apr; 30(4):2473-2481. PubMed ID: 36585536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Race Differences in Gastrostomy Tube Placement After Stroke in Majority-White, Minority-Serving, and Racially Integrated US Hospitals.
    Faigle R; Cooper LA; Gottesman RF
    Dysphagia; 2018 Oct; 33(5):636-644. PubMed ID: 29468269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations of Socioeconomic Variables With Resection, Stage, and Survival in Patients With Early-Stage Pancreatic Cancer.
    Shapiro M; Chen Q; Huang Q; Boosalis VA; Yoon CH; Saund MS; Whang EE; Gold JS
    JAMA Surg; 2016 Apr; 151(4):338-45. PubMed ID: 26581025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Racial and Socioeconomic Treatment Disparities in Adolescents and Young Adults with Stage II-III Rectal Cancer.
    Lee DY; Teng A; Pedersen RC; Tavangari FR; Attaluri V; McLemore EC; Stern SL; Bilchik AJ; Goldfarb MR
    Ann Surg Oncol; 2017 Feb; 24(2):311-318. PubMed ID: 27766558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Compliance with gastric cancer guidelines is associated with improved outcomes.
    Worhunsky DJ; Ma Y; Zak Y; Poultsides GA; Norton JA; Rhoads KF; Visser BC
    J Natl Compr Canc Netw; 2015 Mar; 13(3):319-25. PubMed ID: 25736009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disparities in Receipt of National Comprehensive Cancer Network Guideline-Adherent Care and Outcomes among Women with Triple-Negative Breast Cancer by Race/Ethnicity, Socioeconomic Status, and Insurance Type.
    Ubbaonu CD; Chang J; Ziogas A; Mehta RS; Kansal KJ; Zell JA
    Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Race and Site of Care Impact Treatment Delays in Older Women with Non-Metastatic Breast Cancer.
    Song JH; Kantor O; Mittendorf EA; King TA; Minami CA
    Ann Surg Oncol; 2022 Mar; ():. PubMed ID: 35353260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.